The state-funded, industry-informed research centre providing advanced technology solutions for the pharma-sector has appointed a new director and will expand its research focus to include data analytics. This is all as it launches ‘PMTC Phase 2’ following confirmation of funding from Enterprise Ireland, with support from IDA Ireland.
A key objective for PMTC is to place small and medium enterprises (SMEs) into direct contact with multinational corporations (MNCs) operating in the pharmaceutical and biopharma sectors in Ireland, allowing them to collaborate in an innovative research programme.
The centre funds three core research themes: Plant Cleaning, Process Control & Optimisation and Data Analytics & Utilisation. These programmes are informed by industry and managed through industrial technical teams and the centre steering committee. Innovative research output is offered to PMTC industry members through confidential right of first sights and streamlined commercialisation strategies.
The centre’s industry membership is continuing to grow year on year with the current membership base of 38 companies comprising 60% SMEs and 40% multinationals.
A recent evaluation found the projected Economic Value Add (EVA) of PMTC will be €17.24 for every €1 invested by the State through Enterprise Ireland by 2022. Improved efficiencies and process innovation will be major drivers of this economic impact, with a number of companies reporting potential savings of millions of euro per annum due to implementation of the centre’s research programme.
